Hamburg defends Zohydro approval, pace of progress
By Mari Serebrov
Thursday, March 13, 2014
Senators found much to praise at the FDA, but the pace of progress and recent controversial drug approval decisions raised more than a few eyebrows at a Senate Health, Education, Labor and Pensions (HELP) Committee hearing Thursday.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.